Connection

Andrew Kraft to Growth Substances

This is a "connection" page, showing publications Andrew Kraft has written about Growth Substances.
Connection Strength

0.466
  1. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene. 1999 Jul 08; 18(27):4022-31.
    View in: PubMed
    Score: 0.166
  2. Overexpression of protein kinase C beta 1 is not sufficient to induce factor independence in the interleukin-3-dependent myeloid cell line FDC-P1. Oncogene. 1990 Aug; 5(8):1243-6.
    View in: PubMed
    Score: 0.090
  3. Leukemia-differentiating activity expressed by the human melanoma cell line LD-1. Leuk Res. 1988; 12(3):217-25.
    View in: PubMed
    Score: 0.075
  4. Production of multilineage hemopoietic growth-stimulating activities by a human melanoma cell line. Exp Hematol. 1986 Oct; 14(9):867-72.
    View in: PubMed
    Score: 0.069
  5. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells. Cancer Res. 1993 Feb 01; 53(3):652-7.
    View in: PubMed
    Score: 0.027
  6. Interleukin-3 and bryostatin 1 mediate rapid nuclear envelope protein phosphorylation in growth factor-dependent FDC-P1 hematopoietic cells. A possible role for nuclear protein kinase C. J Biol Chem. 1989 Dec 25; 264(36):21896-901.
    View in: PubMed
    Score: 0.021
  7. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells. Proc Natl Acad Sci U S A. 1987 Dec; 84(23):8483-7.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.